Santen Pharmaceutical Co., Ltd.
SNPHY · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $36,256 | $26,642 | -$14,983 | $27,189 |
| Dep. & Amort. | $17,948 | $18,178 | $17,249 | $17,055 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $10,209 | $14,168 | -$5,059 | $4,706 |
| Other Non-Cash | -$3,485 | $13,661 | $39,940 | -$2,907 |
| Operating Cash Flow | $60,928 | $72,649 | $37,147 | $46,043 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$6,662 | -$9,319 | -$24,588 | -$35,841 |
| Net Acquisitions | $0 | -$207 | -$3,470 | -$2,969 |
| Inv. Purchases | $0 | -$301 | -$589 | -$1,067 |
| Inv. Sales/Matur. | $0 | $4,127 | $2,149 | $3,870 |
| Other Inv. Act. | -$1,561 | -$445 | -$279 | $838 |
| Investing Cash Flow | -$8,223 | -$6,145 | -$26,777 | -$35,169 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$3,313 | -$2,112 | $4,356 | $20,460 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$37,883 | -$16,962 | -$26,007 | -$12 |
| Dividends Paid | -$12,111 | -$11,881 | -$12,607 | -$11,994 |
| Other Fin. Act. | $0 | -$3,076 | -$2,962 | -$2,897 |
| Financing Cash Flow | -$53,307 | -$34,031 | -$37,220 | $5,557 |
| Forex Effect | -$983 | $4,206 | $1,739 | $3,694 |
| Net Chg. in Cash | $92,997 | $36,679 | -$25,111 | $20,126 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $94,582 | $57,903 | $83,014 | $62,888 |
| End Cash | $92,997 | $94,582 | $57,903 | $83,014 |
| Free Cash Flow | $54,266 | $61,962 | $12,559 | $10,202 |